New Jersey-based manufacturers Johnson & Johnson have once again come
under the scrutiny of the Food and Drug Administration (FDA), this time
for defective insulin pumps made by their Animas Corp. unit. However,
the product defects are not the only problems to come to light. The FDA
has also found that J&J delayed reporting two cases of injury due
to the insulin pumps and never reported another, according to the
The three injuries left patients hospitalized for dangerously high blood
sugar which resulted in respiratory failure and coma as their insulin
pumps had failed to inject them with insulin in order to protect them
from the effects of their diabetes while they ate. When a person suffers
from diabetes, they lack the proper amount of insulin, which helps break
down the sugars in their bloodstream and protects them from adverse effects.
As such, medications such as insulin pumps help keep diabetic patients
from building up too much blood sugar and being injured.
When a consumer is injured by a product, manufacturers are required to
report the incident to the FDA within 30 days. J&J claimed that the
injuries resulted from user error; however, the FDA is currently investigating
the reasons behind the failure to report. In addition, the FDA is investigating
J&J’s Animas Corp. for inadequately responding to the agency’s
August inspection, which found problems with the keypads featured on some
of the company’s insulin pumps.
Johnson and Johnson has come under great scrutiny in the past year for
several recalled products, such as hip replacements, and a campaign against
toxic chemicals in baby products.
Manufacturers are not only morally obligated to create safe products in
the U.S., but are legally required to make sure their products do not
harm consumers. A
San Jose dangerous product injury lawyer at Van Der Walde & Associates can help you win the compensation you
deserve for you losses. Call us today at (800) 900-0863.